EMA proposes reflection paper on using external controls to generate evidence
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationClinical TrialsEuropeEuropean Medicines Agency (EMA)PharmaceuticalsProduct developmentProduct LifecycleRegulatory Intelligence/PolicyRegulatory strategyRWE/RWD